Search

Your search keyword '"Schuelter, Eugen"' showing total 4 results
Start Over Author "Schuelter, Eugen" Publication Type Academic Journals
4 results on '"Schuelter, Eugen"'

1. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study

Author

Pett, SL, Amin, J, Horban, A, Andrade‐Villanueva, J, Losso, M, Porteiro, N, Madero, JS, Belloso, W, Tu, E, Silk, D, Kelleher, A, Harrigan, R, Clark, A, Sugiura, W, Wolff, M, Gill, J, Gatell, J, Clarke, A, Ruxrungtham, K, Prazuck, T, Kaiser, R, Woolley, I, Alberto Arnaiz, J, Cooper, D, Rockstroh, JK, Mallon, P, Emery, S, Amin, Janaki, Belloso, Waldo, Clark, Andrew, Clarke, Amanda, Cooper, David, Emery, Sean, Fisher, Martin, Gatell, Jose, Gill, John, Horban, Andrejz, Kaiser, Rolf, Kelleher, Anthony, Losso, Marcelo, Madero, Juan Sierra, Pett, Sarah, Prazuck, Thierry, Rockstroh, Juergen, Ruxrungtham, Kiat, Stellbrink, Jurgen, Sugiura, Wataru, Wolff, Marcelo J, Woolley, Ian, Merlin, Kate, Yeung, Julie, Fsadni, Bertha, Marks, Kat, Suzuki, Kazuo, Rismanto, Nick, Salomon, Horacio, Rubio, Andrea E, Chibo, Doris, Birch, Chris, Harrigan, Richard, Swenson, Luke, Chan, Dennison, Berg, Thomas, Obermeier, Martin, Schuelter, Eugen, Aragon, Saleta Sierra, Luebke, Nadine, Coughlan, Suzie, Dean, Jonathan, Iwatani, Yasumasa, Teran, Gustavo Reyes, Avila, Santiago, Sirivichayakul, Sunee, Naphassanant, May, Ubolyam, Sasiwimol, Kaye, Steve, Land, Sally, Walker, Sarah, Haubrich, Richard, DeJesus, Edwin, Silk, David, Berthon‐Jones, Nisha, Espinosa, Natalie, Courtney‐Vega, Kymme, Absar, Noorul, Haskelberg, Hila, Robson, Rose, Donaldson, Anna, Guelman, Daniel, Gambardella, Luciana, Valdovinos, Mariana, Arnaiz, Juan, Beleta, Helena, Ramos, Nuria, Targa, Marta, Späth, Brigitta, Boesecke, Christoph, Engelhardt, Angelika, Perry, Nicky, Beckthold, Brenda, Drummond, Fraser, Lefevre, Eric, Corr, Sharon, Grant, Carol, Lupo, Sergio, Peroni, Luciana, Sanchez, Marisa, De Paz Sierra, Mariana, Viloria, Guillermo, Parlante, Angel, Bissio, Emiliano, Luchetti, Pablo, Confalonieri, Valeria, Warley, Eduardo, Vieni, Ines, Vilas, Cecilia, Zarate, Abel, Mayer, Gabriela, Elliot, Julian, Hagenauer, Michelle, Kelley, Mark, Rowling, Diane, Gibson, Abby, Latch, Ngaire, Tabrett, Chantal, Warzywoda, Elizabeth, MacRae, Karen, Sinclair, Brett, Sinn, Kate, Bloch, Mark, Franic, Teo, Vincent, Trina, Stewart, Natasha, Jayewardene, Avindra, Dwyer, Dominic, Kok, Jennifer, Assam, Delene, Taylor, Janette, King, Patricia, Orth, David, Youds, David, Sowden, David, Johnston, Colleen, Murray, Suzanne, Hehir, Jennifer, Wadham, Samantha, Donohue, William, Thompson, Jill, Garsia, Roger, Turnham, Geoffrey, Madden, Tracey, Nvene, June, Gillies, Ainsley, Bryant, Mellissa, Walmsley, Sharon, Chan, Warmond, LeBlanc, Roger, Lanteigne, Francois, Mouawad, Rima, Rahal, Ines, Guber, Sergio, Ozturk, Sefika, Smith, Graham, Halpenny, Roberta, Reko, Tatjana, Hills, Jennifer Robinette, Wolff, Marcelo, Allendes, Gladys, Hocqueloux, Francois Laurent, Stephan, Christoph, Ebeling, Franziska, Spath, Brigitta, Jensen, Bjorn‐Erik Ole, Feind, Cecilie, Meyer‐Olson, Dirk, Stoll, Matthias, Hoeper, Kirsten, Beider, Renata, Faetkenheur, Gerd, Thomas, Ellen, Baumgarten, Axel, Ingiliz, Patrick, Wienbreyer, Andreas, Behrendt, Daniela, Nienkarken, Tanja, Jessen, Heiko, Zedlack, Carmen, Mallon, Paddy, Simelane, Sibongile, Assmann, Jennifer, Ghavami‐Kia, Bijan, Imahashi, Mayumi, Tanabe, Kazue, Yokomaku, Yoshiyuki, Imamura, Junji, de Oca, Melva Montes, Gonzalez, Lucero, Ponce, David, Mendoza, Andrea, Sierra‐Madero, Juan, Hernandez, Jesus Eduardo Sanchez, Ballesteros, Eduardo Jaime Ruiz, del Moral Ponce, Sergio, Horban, Andrzej, Ignatowska, Anna, Bakowska, Elzbieta, Pulik, Piotr, Sanz‐Moreno, Jose, Paredes, Roger, Puig, Jordi, Domingo, Pere, Gutierrez, Mar, González‐Cordón, Ana, Callau, Pili, Aldeguer, Jose Lopez, Tovar, Sandra Cuellar, Noval, Manuel Leal, Rivas, Inmaculada, Delgado‐Fernandez, Marcial, Arribas, Jose Ramon, Castro, Juan Miguel, Avihingsanon, Anchalee, Maek‐a‐nantawat, Wirach, Intasan, Jintana, Charoenporn, Walairat, Cuprasitrut, Thidarat, Jaisomkom, Pachuen, Pruksakaew, Kanchana, Winston, Alan, Mullaney, Scott, Barbour, Lisa, Richardson, Celia, Fox, Julie, Murray, Tammy, Teague, Al, Leen, Clifford, Morris, Shelia, Satyajit, Das, Sandhu, Rumun, and Tucker, James

Published
2018
Full Text
View/download PDF

4. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.

Author

Sierra S, Kaiser R, Lübke N, Thielen A, Schuelter E, Heger E, Däumer M, Reuter S, Esser S, Fätkenheuer G, Pfister H, Oette M, and Lengauer T

Subjects
DNA, Viral blood, DNA, Viral chemistry, DNA, Viral genetics, DNA, Viral isolation & purification, HIV Envelope Protein gp120 chemistry, HIV Envelope Protein gp120 genetics, HIV Infections blood, HIV Infections virology, HIV-1 genetics, HIV-1 metabolism, Humans, Oligonucleotide Array Sequence Analysis, Peptide Fragments chemistry, Peptide Fragments genetics, Polymerase Chain Reaction methods, RNA, Viral blood, RNA, Viral chemistry, RNA, Viral genetics, RNA, Viral isolation & purification, Receptors, CCR5 metabolism, Receptors, CXCR4 metabolism, Tropism genetics, env Gene Products, Human Immunodeficiency Virus chemistry, env Gene Products, Human Immunodeficiency Virus genetics, Genotyping Techniques methods, HIV-1 physiology, Tropism physiology
Abstract

Maraviroc (MVC) is the first licensed antiretroviral drug from the class of coreceptor antagonists. It binds to the host coreceptor CCR5, which is used by the majority of HIV strains in order to infect the human immune cells (Fig. 1). Other HIV isolates use a different coreceptor, the CXCR4. Which receptor is used, is determined in the virus by the Env protein (Fig. 2). Depending on the coreceptor used, the viruses are classified as R5 or X4, respectively. MVC binds to the CCR5 receptor inhibiting the entry of R5 viruses into the target cell. During the course of disease, X4 viruses may emerge and outgrow the R5 viruses. Determination of coreceptor usage (also called tropism) is therefore mandatory prior to administration of MVC, as demanded by EMA and FDA. The studies for MVC efficiency MOTIVATE, MERIT and 1029 have been performed with the Trofile assay from Monogram, San Francisco, U.S.A. This is a high quality assay based on sophisticated recombinant tests. The acceptance for this test for daily routine is rather low outside of the U.S.A., since the European physicians rather tend to work with decentralized expert laboratories, which also provide concomitant resistance testing. These laboratories have undergone several quality assurance evaluations, the last one being presented in 2011. For several years now, we have performed tropism determinations based on sequence analysis from the HIV env-V3 gene region (V3). This region carries enough information to perform a reliable prediction. The genotypic determination of coreceptor usage presents advantages such as: shorter turnover time (equivalent to resistance testing), lower costs, possibility to adapt the results to the patients' needs and possibility of analysing clinical samples with very low or even undetectable viral load (VL), particularly since the number of samples analysed with VL < 1000 copies/μl roughly increased in the last years (Fig. 3). The main steps for tropism testing (Fig. 4) demonstrated in this video: Collection of a blood sample Isolation of the HIV RNA from the plasma and/or HIV proviral DNA from blood mononuclear cells Amplification of the env region Amplification of the V3 region Sequence reaction of the V3 amplicon Purification of the sequencing samples Sequencing the purified samples Sequence editing Sequencing data interpretation and tropism prediction.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results